338 related articles for article (PubMed ID: 22314121)
1. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
Manvelian G; Daniels S; Gibofsky A
Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
[TBL] [Abstract][Full Text] [Related]
2. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin.
Manvelian G; Daniels S; Altman R
Postgrad Med; 2012 Jul; 124(4):197-205. PubMed ID: 22913908
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
4. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
Scallion R; Moore KA
Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
Desjardins PJ; Olugemo K; Solorio D; Young CL
Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
[TBL] [Abstract][Full Text] [Related]
6. A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac.
Manvelian G; Daniels S; Gibofsky A
Pain Med; 2012 Nov; 13(11):1491-8. PubMed ID: 23043637
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of diclofenac after oral administration of its potassium salt in sachet and tablet formulations.
Marzo A; Dal Bo L; Verga F; Ceppi Monti N; Abbondati G; Tettamanti RA; Crivelli F; Uhr MR; Ismaili S
Arzneimittelforschung; 2000 Jan; 50(1):43-7. PubMed ID: 10683715
[TBL] [Abstract][Full Text] [Related]
8. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
10. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetic study of rapidly dispersing diclofenac potassium formulations in healthy volunteers.
Lissy M; Stiff DD; Kowalski MM; Moore KA
Curr Med Res Opin; 2009 Oct; 25(10):2423-8. PubMed ID: 19663688
[TBL] [Abstract][Full Text] [Related]
12. Influence of gastric acid secretion blockade and food intake on the bioavailability of a potassium diclofenac suspension in healthy male volunteers.
Poli A; Moreno RA; Ribeiro W; Dias HB; Moreno H; Muscara MN; De Nucci G
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):76-9. PubMed ID: 8929750
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy.
Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE
Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of two different diclofenac formulations in healthy volunteers.
Silva LC; Simões IG; Lerner FE; Belém GR; de Moraes ME; De Nucci G
Arzneimittelforschung; 1999 Nov; 49(11):920-4. PubMed ID: 10604045
[TBL] [Abstract][Full Text] [Related]
20. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
Stampfuss J; Kubitza D; Becka M; Mueck W
Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
